TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32160310

Group type: EXPERIMENTAL
Intervention: Academic-based software tools
Number of subjects: 50

Group type: COMPARATOR
Intervention: Commercial vendor-based software tools
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All software investigated
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All software tools
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: All software tools with quality assurance (QA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Academic-based groups
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Commercial vendors
Number of subjects: 50
Study: 36104745

Group type: COMPARATOR
Intervention: Pregabalin (75 mg twice per day) + placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Pregabalin (75 mg twice per day) + agomelatine (25 mg per night)
Number of subjects: 46
Study: 33619823

Group type: EXPERIMENTAL
Intervention: Routine third-trimester ultrasound
Number of subjects: 508

Group type: COMPARATOR
Intervention: Selective ultrasound based on serial SFH measurements (standard care)
Number of subjects: 508
Study: 32029262

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 0.5 μg kg‐1
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 1.0 μg kg‐1
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 1.5 μg kg‐1
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 2.0 μg kg‐1
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine (all doses)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 36270561

Group type: EXPERIMENTAL
Intervention: Nefecon (16 mg/d)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study: 34972191

Group type: EXPERIMENTAL
Intervention: High granzyme B (GZMB) expression
Number of subjects: 1062

Group type: EXPERIMENTAL
Intervention: Prognostic signature capturing stromal, proliferative and immune functions
Number of subjects: 1062

Group type: EXPERIMENTAL
Intervention: GZMB expression in CMS2 tumor cells
Number of subjects: 1062
Study: 36309040

Group type: EXPERIMENTAL
Intervention: Adolescent Transition Package (ATP)
Number of subjects: 1066

Group type: COMPARATOR
Intervention: Standard-of-care practice (Control)
Number of subjects: 1066
Study: 33600826

Group type: EXPERIMENTAL
Intervention: PACAP38
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sumatriptan
Number of subjects: 35
Study: 36343893

Group type: EXPERIMENTAL
Intervention: 1 mg mocravimod/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3 mg mocravimod/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care GvHD prophylaxis (cyclosporine A/methotrexate or tacrolimus/methotrexate)
Number of subjects: 0
Study: 33107329

Group type: EXPERIMENTAL
Intervention: Binaural beats (DCG-1 and USRG-1)
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Classical music (DCG-2 and USRG-2)
Number of subjects: 411

Group type: COMPARATOR
Intervention: Control (DCG-3 and USRG-3)
Number of subjects: 411
Study: 32240892

Group type: EXPERIMENTAL
Intervention: Patient Initiated Follow Up (PIFU)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Routine CA125 surveillance
Number of subjects: 44

Group type: COMPARATOR
Intervention: Cervical or vault cytology
Number of subjects: 44

Group type: COMPARATOR
Intervention: Telephone follow up
Number of subjects: 44

Group type: COMPARATOR
Intervention: Nurse led follow up
Number of subjects: 44
Study: 33745962

Group type: EXPERIMENTAL
Intervention: Invisible support from a stranger
Number of subjects: 138

Group type: COMPARATOR
Intervention: No support
Number of subjects: 138
Study: 35306633

Group type: EXPERIMENTAL
Intervention: Intensive education intervention (IG) with repeated, structured multimodal education on correct injection techniques.
Number of subjects: 713

Group type: COMPARATOR
Intervention: Control group (CG) with a single educational session.
Number of subjects: 713
Study: 32658253

Group type: EXPERIMENTAL
Intervention: Lanabecestat 20mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36007870

Group type: EXPERIMENTAL
Intervention: Convalescent plasma (CP) therapy (300mL)
Number of subjects: 421

Group type: COMPARATOR
Intervention: Control (non-CP)
Number of subjects: 421
Study: 34536266

Group type: EXPERIMENTAL
Intervention: Endoscopic transtympanic cartilage myringoplasty with removal of perforation edges (n=39)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Endoscopic transtympanic cartilage myringoplasty with preservation of perforation edges (n=40)
Number of subjects: 79
Study: 34193647

Group type: EXPERIMENTAL
Intervention: Intralesional steroids
Number of subjects: 36

Group type: COMPARATOR
Intervention: Systemic steroids
Number of subjects: 36
Study: 33568003

Group type: EXPERIMENTAL
Intervention: Water-based exercises (stationary running, frontal kick, butt kick) at cadences of 80 b·min‐1, 100 b·min‐1, and maximal
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Maximal cadence
Number of subjects: 10

Group type: COMPARATOR
Intervention: Land-based exercises (stationary running, frontal kick, butt kick)
Number of subjects: 10
Study: 32683489

Group type: EXPERIMENTAL
Intervention: HYPO (normobaric hypoxia with FiO2 set to 13.5%) during post-exercise muscle ischemia (PEMI)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: NORMO (normoxia) during post-exercise muscle ischemia (PEMI)
Number of subjects: 11

Group type: COMPARATOR
Intervention: HYPO (normobaric hypoxia with FiO2 set to 13.5%) during control exercise recovery session
Number of subjects: 11

Group type: COMPARATOR
Intervention: NORMO (normoxia) during control exercise recovery session
Number of subjects: 11
Study: 34933665

Group type: EXPERIMENTAL
Intervention: Social work case management intervention
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 169
Study: 33346499

Group type: EXPERIMENTAL
Intervention: Radiofrequency renal artery denervation (RND)
Number of subjects: 0
Study: 35821110

Group type: EXPERIMENTAL
Intervention: VR training group (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: SG group (n = 10)
Number of subjects: 20
Study: 33683643

Group type: EXPERIMENTAL
Intervention: Energy Healing (EH) therapy with three sessions
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard operative care (Control)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Energy Healing (EH) therapy
Number of subjects: 50
Study: 33095199

Group type: EXPERIMENTAL
Intervention: Wet weather conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Restricted wave action sites
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ampicillin resistance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minimum inhibitory concentration testing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-restricted wave action sites
Number of subjects: 0
Study: 35688036

Group type: EXPERIMENTAL
Intervention: BS self-etching sealant (BeautiSealant-Shofu)
Number of subjects: 28

Group type: COMPARATOR
Intervention: FS conventional sealant (Fluoroshield-Dentsply)
Number of subjects: 28
Study: 33973384

Group type: EXPERIMENTAL
Intervention: Tanezumab 2.5-10 mg every 8 weeks
Number of subjects: 1840

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1840

Group type: EXPERIMENTAL
Intervention: Tanezumab 5 mg
Number of subjects: 1840

Group type: EXPERIMENTAL
Intervention: Tanezumab (5.9-7.0%)
Number of subjects: 1840

Group type: EXPERIMENTAL
Intervention: Tanezumab 2.5-10 mg
Number of subjects: 1840

Group type: EXPERIMENTAL
Intervention: Tanezumab 2.5-5 mg
Number of subjects: 1840
Study: 34690287

Group type: EXPERIMENTAL
Intervention: Single-leg knee extension (SLKE) training (n = 12)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Passive stretching training (PST) (n = 12)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no intervention) (n = 12)
Number of subjects: 36
Study: 34677609

Group type: EXPERIMENTAL
Intervention: Transcranial direct current brain stimulation (tDCS; 2 mA) for 20 minutes before chemotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 60
Study: 32128971

Group type: EXPERIMENTAL
Intervention: Posttransplant exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 0
Study: 35101271

Group type: EXPERIMENTAL
Intervention: TAVI
Number of subjects: 138

Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: TAVI and SAVR
Number of subjects: 138
Study: 32949673

Group type: EXPERIMENTAL
Intervention: Aversive motivational state
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Appetitive motivational state
Number of subjects: 102
Study: 35354637

Group type: EXPERIMENTAL
Intervention: BP self-monitoring and tele-monitoring plus a free SPC-based telemedicine titration therapy for 6 months
Number of subjects: 358

Group type: COMPARATOR
Intervention: Self-monitoring BP without any therapy change
Number of subjects: 358
Study: 35175066

Group type: EXPERIMENTAL
Intervention: Low dose alcohol condition (BrAC = .04%)
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: High dose alcohol condition (BrAC = .08%)
Number of subjects: 313

Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 313

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 313
Study: 32568433

Group type: EXPERIMENTAL
Intervention: Nitroglycerin infusion (0.5 µg/kg/min)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 35270330

Group type: EXPERIMENTAL
Intervention: Active Video Games (AVG) intervention combined with multicomponent exercise, 5 months, 3 sessions per week
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (CG) continued daily activities without modification
Number of subjects: 29
Study: 33752609

Group type: EXPERIMENTAL
Intervention: Peer leader diabetes self-management support (PLDSMS) intervention
Number of subjects: 0
Study: 32749942

Group type: EXPERIMENTAL
Intervention: Olaparib (300 mg twice daily)
Number of subjects: 0
Study: 36226043

Group type: EXPERIMENTAL
Intervention: ECCE Malaysian government policy education
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: Government education on ECCE
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: Focus group interviews
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: Improvement of ECCE policies
Number of subjects: 629
Study: 32223444

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 4614

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 4614

Group type: COMPARATOR
Intervention: Vitamin K Antagonist (VKA)
Number of subjects: 4614

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4614
Study: 35724840

Group type: EXPERIMENTAL
Intervention: Structured transition program delivered over 15 months
Number of subjects: 156

Group type: COMPARATOR
Intervention: Usual care from the pediatric site
Number of subjects: 156
Study: 34282949

Group type: EXPERIMENTAL
Intervention: Genetically predicted Lp(a) levels
Number of subjects: 908087

Group type: EXPERIMENTAL
Intervention: Mendelian randomization-phenome-wide association analyses
Number of subjects: 908087
Study: 35883115

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behaviour therapy (CBT) for 10 weeks
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behaviour therapy (CBT)
Number of subjects: 90
Study: 33417105

Group type: EXPERIMENTAL
Intervention: Fathers present in the household
Number of subjects: 2533

Group type: COMPARATOR
Intervention: Fathers deceased and adult males absent
Number of subjects: 2533

Group type: EXPERIMENTAL
Intervention: Fathers deceased but other adult males present
Number of subjects: 2533
Study: 32317000

Group type: EXPERIMENTAL
Intervention: SALTCHECKER (with a smart salt checker and a salt-limiting WeChat mini programme)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Salt checker (with only a weighing function)
Number of subjects: 0
Study: 36153481

Group type: EXPERIMENTAL
Intervention: Culturally tailored Facebook banner ads
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-tailored Facebook banner ads
Number of subjects: 0
Study: 33565715

Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation (4000 IU daily)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation
Number of subjects: 193
Study: 33095774

Group type: EXPERIMENTAL
Intervention: Online feedback during practice (group 2, 3, and 4)
Number of subjects: 44

Group type: COMPARATOR
Intervention: No feedback during practice (group 1, control)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Target coordination = 180° (group 4)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Target coordination = 0° (group 2)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Target coordination = 90° (group 3)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Spontaneous coordination
Number of subjects: 44
Study: 35943205

Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trial (RCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Natural Experiment
Number of subjects: 0
Study: 33976543

Group type: EXPERIMENTAL
Intervention: umeclidinium/vilanterol
Number of subjects: 2425

Group type: COMPARATOR
Intervention: umeclidinium
Number of subjects: 2425

Group type: COMPARATOR
Intervention: salmeterol
Number of subjects: 2425

Group type: EXPERIMENTAL
Intervention: CII at Week 4
Number of subjects: 2425

Group type: EXPERIMENTAL
Intervention: No CII at Week 4
Number of subjects: 2425
Study: 32073316

Group type: EXPERIMENTAL
Intervention: Oral vitamin C (1,500 mg per day in three divided doses) from the first postoperative day
Number of subjects: 400

Group type: COMPARATOR
Intervention: Routine postoperative medications with placebo
Number of subjects: 400
Study: 36262834

Group type: EXPERIMENTAL
Intervention: Auricular plaster therapy (APT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham auricular plaster therapy
Number of subjects: 44
Study: 32128593

Group type: EXPERIMENTAL
Intervention: dCBT
Number of subjects: 410

Group type: COMPARATOR
Intervention: wait-list control
Number of subjects: 410
Study: 34407547

Group type: EXPERIMENTAL
Intervention: Umbilical cord blood (UCB)
Number of subjects: 80
Study: 33832661

Group type: EXPERIMENTAL
Intervention: Secondary Mitral Regurgitation (SMR)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Primary Mitral Regurgitation (PMR)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Normal Valves
Number of subjects: 106
Study: 36207981

Group type: COMPARATOR
Intervention: Steatotic donor liver group (n=81)
Number of subjects: 814

Group type: COMPARATOR
Intervention: Mild and moderate steatosis groups (n=81)
Number of subjects: 814
Study: 34696820

Group type: EXPERIMENTAL
Intervention: Patient-supporting intervention delivered by dermatology nurses
Number of subjects: 114

Group type: COMPARATOR
Intervention: Standard procedure (non-intervention)
Number of subjects: 114
Study: 33022197

Group type: EXPERIMENTAL
Intervention: SKNB19 (twice a day application)
Number of subjects: 18

Group type: COMPARATOR
Intervention: HQ4% (nightly application)
Number of subjects: 18
Study: 36266615

Group type: EXPERIMENTAL
Intervention: Computer-aided rowing exercise (CRE)
Number of subjects: 38
Study: 34416023

Group type: EXPERIMENTAL
Intervention: Romiplostim
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-of-Care (SOC)
Number of subjects: 0
Study: 33810414

Group type: EXPERIMENTAL
Intervention: High-Protein (HP) diet
Number of subjects: 35

Group type: COMPARATOR
Intervention: Low Glycemic Index (LGI) diet
Number of subjects: 35
Study: 32019482

Group type: EXPERIMENTAL
Intervention: Artificial Turf (AT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Natural Turf (NT)
Number of subjects: 18
Study: 35430494

Group type: EXPERIMENTAL
Intervention: Education and contact group
Number of subjects: 121

Group type: COMPARATOR
Intervention: Education only group
Number of subjects: 121
Study: 33523474

Group type: EXPERIMENTAL
Intervention: RO7049389
Number of subjects: 0
Study: 32103298

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35727626

Group type: EXPERIMENTAL
Intervention: Unguided IBI using cognitive behavior therapy
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Text support condition (asynchronous clinician support through text)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Video support condition (asynchronous clinician support through video)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Guided IBI (text and video support)
Number of subjects: 145
Study: 32032740

Group type: EXPERIMENTAL
Intervention: FAM21 (21 sessions of focused attention meditation)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: FAM1 (single session of focused attention meditation)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control (no preceding FAM)
Number of subjects: 29
Study: 35320361

Group type: EXPERIMENTAL
Intervention: 80 μg dasiglucagon
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 200 μg dasiglucagon
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 32347302

Group type: EXPERIMENTAL
Intervention: Hippocampal-sparing whole brain irradiation with simultaneous integrated boost (HSIB-WBRT)
Number of subjects: 50
Study: 34415795

Group type: EXPERIMENTAL
Intervention: Topical lotilaner ophthalmic solution, 0.25%, treated bid for 42 days
Number of subjects: 18
Study: 32397113

Group type: EXPERIMENTAL
Intervention: lenalidomide
Number of subjects: 56
Study: 34326044

Group type: EXPERIMENTAL
Intervention: Nurse-led non-pharmacological intervention
Number of subjects: 18
Study: 33814901

Group type: EXPERIMENTAL
Intervention: Oronasal mask
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nasal mask
Number of subjects: 30
Study: 32275032

Group type: EXPERIMENTAL
Intervention: Ketorolac 120 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paracetamol 4 g
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine 20 mg
Number of subjects: 0
Study: 36181047

Group type: EXPERIMENTAL
Intervention: XGBoost model with variables related to intravenous (IV) fluid management and electrolytes
Number of subjects: 1185

Group type: COMPARATOR
Intervention: XGBoost model without variables related to IV fluid management and electrolytes
Number of subjects: 1185
Study: 34044245

Group type: EXPERIMENTAL
Intervention: Daily antioxidant supplement comprising polyphenols, omega‐3 fatty acids, vitamin E, and selenium
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no antioxidant supplementation)
Number of subjects: 20
Study: 34881510

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Low-fat diet (LFD)
Number of subjects: 44
Study: 32916063

Group type: EXPERIMENTAL
Intervention: Met+SU+Voglibose
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Met+Voglibose
Number of subjects: 110
Study: 32026568

Group type: EXPERIMENTAL
Intervention: Small-quantity lipid-based nutrient supplements (LNS) during pregnancy and 6 months postpartum
Number of subjects: 799

Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MMN) during pregnancy and 6 months postpartum (Ghana only)
Number of subjects: 799

Group type: COMPARATOR
Intervention: Iron plus folic acid (IFA) during the index pregnancy (Ghana) or during and for 3 months after the index pregnancy (Bangladesh)
Number of subjects: 799
Study: 36506062

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival (OS)
Number of subjects: 3480

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cancer-specific survival (CSS)
Number of subjects: 3480

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting 1-, 3-, and 5-year OS rates
Number of subjects: 3480

Group type: EXPERIMENTAL
Intervention: Nomogram for clinical decision-making
Number of subjects: 3480
Study: 36163945

Group type: EXPERIMENTAL
Intervention: Pegcetacoplan
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control
Number of subjects: 53
Study: 33689606

Group type: EXPERIMENTAL
Intervention: Lotrafilcon B (Air Optix Aqua, Ciba Vision)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Balafilcon A (Pure Vision 2 HD, Bausch+Lomb)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both lenses
Number of subjects: 49
Study: 33050931

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg or 25 mg
Number of subjects: 7020

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7020

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 7020
Study: 35998300

Group type: EXPERIMENTAL
Intervention: T-VEC-pembrolizumab
Number of subjects: 692

Group type: COMPARATOR
Intervention: Placebo-pembrolizumab
Number of subjects: 692
Study: 34389547

Group type: EXPERIMENTAL
Intervention: Usual care plus point‐of‐care PlGF testing
Number of subjects: 2313

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2313
Study: 32014806

Group type: EXPERIMENTAL
Intervention: Platelet transfusion over 30-45 min
Number of subjects: 11

Group type: COMPARATOR
Intervention: Standard platelet transfusion over 2-4 h
Number of subjects: 11
Study: 34809475

Group type: EXPERIMENTAL
Intervention: Temporary basal rate and extended bolus features in addition to basal insulin modifications
Number of subjects: 30

Group type: COMPARATOR
Intervention: Basal insulin adjustments only
Number of subjects: 30
Study: 32750143

Group type: EXPERIMENTAL
Intervention: abemaciclib + ET
Number of subjects: 1138

Group type: COMPARATOR
Intervention: placebo + ET
Number of subjects: 1138
Study: 32223446

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18924

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18924
Study: 34420200

Group type: EXPERIMENTAL
Intervention: Vitamin-containing amino acid supplement (LGA group)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 37
Study: 35966733

Group type: EXPERIMENTAL
Intervention: Warm needle acupuncture plus Xitong Waixi lotion
Number of subjects: 80

Group type: COMPARATOR
Intervention: Xitong Waixi lotion
Number of subjects: 80
Study: 33449836

Group type: EXPERIMENTAL
Intervention: Laparoscopic Banded Sleeve Gastrectomy (LBSG)
Number of subjects: 209
Study: 35401060

Group type: EXPERIMENTAL
Intervention: Two-day workshop on blood pressure and reducing salt consumption for health personnel and an eight-session workshop for mothers on reducing salt intake and blood pressure.
Number of subjects: 200
Study: 35785965

Group type: EXPERIMENTAL
Intervention: Guideline-based regular exercise (EXE)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Guideline-based regular exercise and 15-min postexercise sauna (EXS)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 47